Study of Salirasib to Treat Non-Small Cell Lung Cancer

Clinical trial NCT00531401 · COMPLETED

Trial details

NCT number: NCT00531401
Sponsor: Concordia Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2007-09-01
Primary completion: 2009-11-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.